Tirzepatide 30mg vial claims: what the evidence actually shows

What did @brokebestiebudgeting actually say?

The creator walks through reconstituting a 30mg compounded tirzepatide vial using "120 units of bacteriostatic water," describes starting at "2.5 milligrams, which equals 10 units," and explains why they switched from semaglutide. They also note you should never shake peptides, and openly admit they only know how to do this specific process for the 30mg and 60mg vials.

To their credit, they are unusually transparent about the limits of their knowledge, explicitly telling viewers not to ask them how to reconstitute anything else. That disclaimer matters, but it does not undo the fact that they are demonstrating a medical compounding procedure on TikTok to 36,000 viewers with no clinical framing.

Does the science back this up?

On the core pharmacology claim, yes, mostly. Tirzepatide does work differently than semaglutide, and the clinical data on weight loss outcomes does favor tirzepatide. The creator is not making up the mechanism.

The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) found that tirzepatide at 15mg produced mean weight reduction of up to 22.5% of body weight over 72 weeks in adults with obesity. For comparison, the STEP 1 trial (Wilding et al., 2021, NEJM) showed semaglutide 2.4mg producing around 14.9% weight reduction. So the creator's claim that tirzepatide is "a lot more effective" for weight loss is backed by head-to-comparison data. The SURMOUNT-5 trial (2025) directly compared the two and showed tirzepatide producing approximately 47% greater relative weight loss.

The GIP mechanism description is partially correct but simplified to the point of being misleading, which is addressed below.

What did they get wrong (or right)?

The creator says tirzepatide "activates GIP which just enhances insulin secretion and also slows down the time it takes for food to leave your stomach." This conflates two separate mechanisms and gets the gastric emptying attribution wrong.

Gastric emptying delay is primarily a GLP-1 effect, not a GIP effect. GIP's role in tirzepatide's action is more about adipose tissue, glucagon suppression context-dependently, and energy metabolism than gastric motility. Drucker (2022, Cell Metabolism) and others have noted that GIP receptor agonism in tirzepatide likely works partly by enhancing GLP-1 receptor signaling rather than acting as a straightforward additive pathway.

The "bacteriostatic water" call is technically correct for reconstitution purposes, not sterile water. That is a real and important distinction. The "do not shake" instruction is also correct. Peptide aggregation from shaking is a documented stability concern.

What is genuinely problematic: demonstrating self-injection reconstitution of compounded tirzepatide without any mention that compounded tirzepatide is not FDA-approved, is not equivalent to Zepbound or Mounjaro, and carries real risks around sterility, dosing accuracy, and sourcing.

What should you actually know?

Compounded tirzepatide is not the same product as Zepbound or Mounjaro. This is not a technicality. The FDA has raised specific concerns about compounded GLP-1 products, including inconsistent potency and sterility. In 2024 and 2025, the FDA flagged adverse event reports tied to compounded semaglutide and tirzepatide, including dosing errors from unit conversion mistakes, which is exactly the kind of calculation this video walks through.

The unit conversion math shown here (30mg vial plus 120 units bacteriostatic water yielding 10 units per 2.5mg dose) may be accurate for this specific setup, but unit-based dosing on insulin syringes is a known source of error with high-concentration peptide vials. A miscalculation does not produce a slightly wrong dose. It can produce a dose that is ten times too high.

Self-injection of any compound from an unregulated source carries infection risk, dosing risk, and zero recourse if something goes wrong. If you are considering tirzepatide for weight management, that conversation belongs with a licensed provider who can evaluate your history, prescribe an appropriate dose, and monitor your response.